Selective pharmacological agents implicate mitochondrial but not sarcolemmal K(ATP) channels in ischemic cardioprotection

Circulation

Volumn 101, Issue 20, 2000, Pages 2418-2423

  Sato, Toshiaki ^a,b   Sasaki, Norihito ^a   Seharaseyon, Jegatheesan ^a   O'Rourke, Brian ^a   Marbán, Eduardo ^a  

^a JOHNS HOPKINS UNIVERSITY   (United States)

^b OITA UNIVERSITY   (Japan)

Author keywords

Ischemia; Mitochondria; Potassium; Preconditioning

Indexed keywords

2 CYANO 1 (1,1 DIMETHYLPROPYL) 3 (3 PYRIDYL)GUANIDINE; 5 HYDROXYDECANOIC ACID; ADENOSINE TRIPHOSPHATASE (POTASSIUM); CLAMIKALANT; DIAZOXIDE; FLAVOPROTEIN; POTASSIUM CHANNEL; POTASSIUM CHANNEL BLOCKING AGENT; POTASSIUM CHANNEL STIMULATING AGENT; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CELL DAMAGE; CONTROLLED STUDY; HEART PROTECTION; MITOCHONDRION; NONHUMAN; NUCLEOTIDE SEQUENCE; OXIDATION; PRIORITY JOURNAL; RABBIT; SARCOLEMMA;

EID: 0034704992     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.101.20.2418     Document Type: Article

References (32)

1. Murry CE, Jennings RB, Reimer KA. Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium. Circulation. 1986; 74:1124-1136.
2. + channels in cardiac muscle. Nature. 1983; 305:147-148.
3. + channel in the mitochondrial inner membrane. Nature. 1991;352:244-247.
4. Vander Heide RS, Rim D, Hohl CM, Ganote CE. An in vitro model of myocardial ischemia utilizing isolated adult rat myocytes. J Mol Cell Cardiol. 1990;22:165-181.
5. + blocker dofetilide. Am J Physiol. 1996;40:H1207-H1214.
6. ATP channel opener bimakalim on coronary blood flow, monophasic action potential duration, and infarct size in dogs. Circulation. 1994;89:1769-1775.
7. ATP channel. Am J Physiol. 1996;40:H1769-H1777.
8. Liu Y, Sato T, O'Rourke B, Marban E. Mitochondrial ATP-dependent potassium channels: novel effectors of cardioprotection? Circulation. 1998;97:2463-2469.
9. + channels: possible mechanism of cardioprotection. Circ Res. 1997;81:1072-1082.
10. + channels by protein kinase C. Circ Res. 1998;83:110-114.
11. ATP channels. Mol Pharmacol. 1999;55:1000-1005.
12. Auchampach JA, Grover GJ, Gross GJ. Blockade of ischaemic preconditioning in dogs by the novel ATP dependent potassium channel antagonist sodium 5-hydroxydecanoate. Cardiovasc Res. 1992;26:1054-1062.
13. Hide EJ, Thiemermann C. Limitation of myocardial infarct size in the rabbit by ischaemic preconditioning is abolished by sodium 5-hydroxydecanoate. Cardiovasc Res. 1996;31:941-946.
14. ATP channel antagonist, 5-hydroxydecanoate, blocks ischemic preconditioning in the rat heart. J Mol Cell Cardiol. 1997;29:1055-1060.
15. Gögelein H, Hartung J, Englert HC, Schölkens BA. HMR 1883, a novel cardioselective inhibitor of the ATP-sensitive potassium channel, I: effects on cardiomyocytes, coronary flow and pancreatic β-cells. J Pharmacol Exp Ther. 1998;286:1453-1464.
16. + channels in guinea pig ventricular cells. J Pharmacol Exp Ther. 1993;266:978-984.
17. + currents by protein kinase C and adenosine: implications for ischemic preconditioning. Circ Res. 1996;78:443-454.
18. Chance B, Salkovitz IA, Kovach AG. Kinetics of mitochondrial flavoprotein and pyridine nucleotide in perfused heart. Am J Physiol. 1972; 223:207-218.
19. Hajnoczky G, Robb-Gaspers LD, Seitz MB, Thomas AP. Decoding of cytosolic calcium oscillations in the mitochondria. Cell. 1995;82: 415-424.
20. ATP channel as a receptor for potassium channel openers. J Biol Chem. 1996;271:8796-8799.
21. Sargent CA, Sleph PG, Dzwonczyk S, Normandin D, Antonaccio MJ, Crover GJ. Cardioprotective effects of the cyanoguanidine potassium channel opener P-1075. J Cardiovasc Pharmacol. 1993;22:564-570.
22. + channels. Neuron. 1996;16: 1011-1017.
23. + channel. J Physiol (Lond). 1997;499:715-720.
24. Gross GJ, Auchampach JA. Blockade of ATP-sensitive potassium channels prevents myocardial preconditioning in dogs. Circ Res. 1992; 70:223-233.
25. Armstrong SC, Liu GS, Downey JM, Ganote CE. Potassium channels and preconditioning of isolated rabbit cardiomyocytes: effects of glyburide and pinacidil. J Mol Cell Cardiol. 1995;27:1765-1774.
26. Mizumura T, Nithipatikom K, Gross GJ. Bimakalim, an ATP-sensitive potassium channel opener, mimics the effects of ischemic preconditioning to reduce infarct size, adenosine release, and neutrophil function in dogs. Circulation. 1995;92:1236-1245.
27. Grimmsmann T, Rustenbeck I. Direct effects of diazoxide on mitochondria in pancreatic β-cells and on isolated liver mitochondria. Br J Pharmacol. 1998;123:781-788.
28. Moritani K, Miyazaki T, Miyoshi S, Asanagi M, Zhao LS, Mitamura H, Ogawa S. Blockade of ATP-sensitive potassium channels by 5-hydroxydecanoate suppresses monophasic action potential shortening during regional ischemia. Cardiovasc Drugs Ther. 1994;8:749-756.
29. + in ischemic guinea-pig heart. Eur J Pharmacol. 1998;348:31-35.
30. ATP channels and actin cytoskeleton. Am J Physiol. 1999;276: H1361-H1368.
31. Cohen MV, Downey JM. Ischemic preconditioning: can the protection be bottled? Lancet. 1993;342:6.
32. +-ATPase modulates ischemic preconditioning. Circulation. 1998;98:2905-2910.